chr15-98769512-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000875.5(IGF1R):c.640+61405A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.602 in 152,032 control chromosomes in the GnomAD database, including 29,265 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.60   (  29265   hom.,  cov: 32) 
Consequence
 IGF1R
NM_000875.5 intron
NM_000875.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.521  
Publications
2 publications found 
Genes affected
 IGF1R  (HGNC:5465):  (insulin like growth factor 1 receptor) This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014] 
IGF1R Gene-Disease associations (from GenCC):
- growth delay due to insulin-like growth factor I resistanceInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.703  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.602  AC: 91478AN: 151914Hom.:  29263  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
91478
AN: 
151914
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.602  AC: 91480AN: 152032Hom.:  29265  Cov.: 32 AF XY:  0.602  AC XY: 44724AN XY: 74302 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
91480
AN: 
152032
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
44724
AN XY: 
74302
show subpopulations 
African (AFR) 
 AF: 
AC: 
15046
AN: 
41466
American (AMR) 
 AF: 
AC: 
10375
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2583
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2884
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
2744
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
7680
AN: 
10538
Middle Eastern (MID) 
 AF: 
AC: 
169
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
48124
AN: 
67980
Other (OTH) 
 AF: 
AC: 
1255
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1718 
 3435 
 5153 
 6870 
 8588 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 756 
 1512 
 2268 
 3024 
 3780 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1767
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.